Bibliographic Details
| Title: |
The Underlying Molecular Mechanisms of the Placenta Accreta Spectrum: A Narrative Review. |
| Authors: |
Lizárraga-Verdugo, Erik1 (AUTHOR) eriklizarraga@uas.edu.mx, Beltrán-Ontiveros, Saúl Armando1 (AUTHOR) saul.beltran@uas.edu.mx, Gutiérrez-Grijalva, Erick Paul2 (AUTHOR) erickpaulggrijalva@gmail.com, Montoya-Moreno, Marisol1 (AUTHOR) marisol.montoya@uas.edu.mx, Gutiérrez-Arzapalo, Perla Y.1 (AUTHOR) perla.gutierrez@uas.edu.mx, Avendaño-Félix, Mariana3 (AUTHOR) marianaavendano@uas.edu.mx, Gutiérrez-Castro, Karla Paola1 (AUTHOR) karla.gutierrez@uas.edu.mx, Cuén-Lazcano, Daniel E.1 (AUTHOR) daniel.cuen@uas.edu.mx, González-Quintero, Paul4 (AUTHOR) drpol@hotmail.es, Mora-Palazuelos, Carlos Ernesto1 (AUTHOR) carlospalazuelos@uas.edu.mx |
| Source: |
International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 17, p9722. 13p. |
| Subject Terms: |
*SCIENTIFIC literature, *PLACENTA accreta, *GENE expression, *NOTCH signaling pathway, *NON-coding RNA, *CESAREAN section |
| Abstract: |
Placenta accreta spectrum (PAS) disorders are characterized by abnormal trophoblastic invasion into the myometrium, leading to significant maternal health risks. PAS includes placenta accreta (invasion < 50% of the myometrium), increta (invasion > 50%), and percreta (invasion through the entire myometrium). The condition is most associated with previous cesarean deliveries and increases in chance with the number of prior cesarians. The increasing global cesarean rates heighten the importance of early PAS diagnosis and management. This review explores genetic expression and key regulatory processes, such as apoptosis, cell proliferation, invasion, and inflammation, focusing on signaling pathways, genetic expression, biomarkers, and non-coding RNAs involved in trophoblastic invasion. It compiles the recent scientific literature (2014–2024) from the Scopus, PubMed, Google Scholar, and Web of Science databases. Identifying new biomarkers like AFP, sFlt-1, β-hCG, PlGF, and PAPP-A aids in early detection and management. Understanding genetic expression and non-coding RNAs is crucial for unraveling PAS complexities. In addition, aberrant signaling pathways like Notch, PI3K/Akt, STAT3, and TGF-β offer potential therapeutic targets to modulate trophoblastic invasion. This review underscores the need for interdisciplinary care, early diagnosis, and ongoing research into PAS biomarkers and molecular mechanisms to improve prognosis and quality of life for affected women. [ABSTRACT FROM AUTHOR] |
|
Copyright of International Journal of Molecular Sciences is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
|
Full text is not displayed to guests. |
Login for full access.
|
